Author(s):
Senotrusova Sofya Dmitrievna
Position: Junior Research Scientist
Office: Federal Research Center for Information and Computational Technologies
Address: 630090, Russia, Novosibirsk, Academician M.A. Lavrentiev avenue, 6
E-mail: senotrusova.s@mail.ru
SPIN-code: 2066-6054

Voropaeva Olga Falaleevna
Dr.
Position: Leading research officer
Office: Federal Research Centerfor Information and Computational Technologies
Address: 630090, Russia, Novosibirsk, ac. Lavrentyev Avenue, 6
Phone Office: (383) 330-85-70
E-mail: vorop@ict.nsc.ru
SPIN-code: 6550-0849

Shokin Yuriy Ivanovich
Dr. , Academician RAS, Professor
Position: Scientific Director of the Institute
Office: Federal Research Center for Information and Computational Technologies
Address: 630090, Russia, Novosibirsk, Ac. Lavrentiev ave., 6
Phone Office: (383) 334 91 10
E-mail: shokin@ict.nsc.ru
SPIN-code: 6442-4180

References:
1. Almazov V.P., Kochetkov D.V., Chumakov P.M. Use of p53 for therapy of human cancer. Molecular Biology. 2007; 41(6):863–877. (In Russ.)

2. Zheltukhin A.O., Chumakov P.M. Everyday and induced functions of the p53 gene. Advances in Biological Chemistry. 2010; (50):447–516. (In Russ.)

3. Lane D., Levine A. p53 Research: the past thirty years and the next thirty years. Cold Spring Harb. Perspect. 2010; 2(12):a000893.

4. Geva-Zatorsky N., Rosenfeld N., Itzkovitz Sh. et al. Oscillations and variability in the p53 system. Molecular Systems Biology. 2006; 2(1):2006.0033.

5. Batchelor E., Mock C.S., Bhan I., Loewer A., Lahav G. Recurrent initiation: A mechanism for triggering p53 pulses in response to DNA damage. Molecular Cell. 2008; 30(3):277–289.

6. Toettcher J.E., Mock C., Batchelor E., Loewer A., Lahav G. A synthetic-natural hybrid oscillator in human cells. PNAS. 2010; 107(39):17047–17052.

7. Paek A.L., Liu J.C., Loewer A., Forrester W.C., Lahav G. Cell-to-cell variation in p53 dynamics leads to fractional killing. Cell. 2016; 165(3):631–642.

8. Jovanovic K.K., Escure G., Demonchy J., Willaume A., Van de Wyngaert Z., Farhat M., Chauvet P., Facon T., Quesnel B., Manier S. Deregulation and targeting of TP53 pathway in multiple myeloma. Frontiers in Oncology. 2019; 8(3):665.

9. Handa H., Murakami Yu., Ishihara R., Kimura-Masuda K., Masuda Yu. The role and function of microRNA in the pathogenesis of multiple myeloma. Cancers (Basel). 2019; 11(11):1738.

10. Zhu B., Ju S., Chu H., Shen X., Zhang Y., Luo X., Cong H. The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma. Oncology Letters. 2018; (15):6094–6106.

11. Zhang X., Wan G., Mlotshwa S., Vance V., Berger F.G., Chen H., Lu X. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway. Cancer Research. 2010; (70):7176–7186.

12. Issler M.V.C., Mombach J.C.M. MicroRNA-16 feedback loop with p53 and Wip1 can regulate cell fate determination between apoptosis and senescence in DNA damage response. PLoS ONE. 2017; (12):e0185794.

13. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., Zhai Y., Giordano T.J., Qin Z.S., Moore B.B. et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Current Biology. 2007; (17):1298–1307.

14. Yamakuchi M., Lowenstein C.J. MiR-34, SIRT1, and p53: the feedback loop. Cell Cycle. 2009; (8):712–715.

15. Neault M., Couteau F., Bonneau E., De Guire V., Mallette F.A. Molecular regulation of cellular senescence by microRNAs: implications in cancer and age-related diseases. International Review of Cell and Molecular Biology. 2017; (334):27–98.

16. Zhang J., Sun Q., Zhang Z., Ge S., Han Z.G., Chen W.T. Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the Mdm2 — p53 feedback loop. Oncogene. 2013; (32):61–69.

17. Pichiorri F., Suh S.S., Rocci A., De Luca L., Taccioli C., Santhanam R., Zhou W., Benson D.M.Jr., Hofmainster C., Alder H. et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell. 2010; (18):367–381.

18. Fornari F., Milazzo M., Galassi M., Callegari E., Veronese A., Miyaaki H., Sabbioni S., Mantovani V., Marasco E., Chieco P. et al. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma. Molecular Cancer Research. 2014; (12):203–216.

19. Navarro F., Lieberman J. miR-34 and p53: New insights into a complex functional relationship. PLoS ONE. 2015; (10):e0132767.

20. Yu J., Baron V., Mercola D., Mustelin T., Adamson E.D. A network of p73, p53 and Egr1 is required for effcient apoptosis in tumor cells. Cell Death and Differentiation. 2007; (14):436–446.

21. Kato R., Mizuno S., Kadowaki M., Shiozaki K., Akai M., Nakagawa K., Oikawa T., Iguchi M., Osanai K., Ishizaki T. et al. Sirt1 expression is associated with CD31 expression in blood cells from patients with chronic obstructive pulmonary disease. Respiratory Research. 2016; (17):139.

22. Castro R.E., Ferreira D.M.S., Afonso M.B., Borralho P.M., Machado M.V., CortezPinto H., Rodrigues C.M. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. Journal of Hepatology. 2013; 58(1):119–125.

23. Baker J.R., Vuppusetty C., Colley T., Papaioannou A.I., Fenwick P., Donnelly L., Ito K., Barnes P.J. Oxidative stress dependent microRNA-34a activation via PI3Kα reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells. Scientific Reports. 2016; (6):35871.

24. Batchelor E., Loewer A. Recent progress and open challenges in modeling p53 dynamics in single cells. Current Opinion in Systems Biology. 2017; (3):54–59.

25. Voropaeva O.F., Senotrusova S.D., Shokin Yu.I. Deregulation of p53-dependent microRNAs: The results of mathematical modeling. Mathematical Biology and Bioinformatics. 2017; 12(1):151–175. (In Russ.)

26. Voropaeva O.F., Lisachev P.D., Senotrusova S.D., Shokin Yu.I. Hyperactivation of the p53microrna signaling pathway: Mathematical model of variants of antitumor therapy. Mathematical Biology and Bioinformatics. 2019; 14(1):355–372. (In Russ.)

27. Senotrusova S.D., Voropaeva O.F. Mathematical modeling of a positive connection in the p53 — microRNA tumor marker system. Numerical Analysis and Applications. 2019; 12(3):270–283. (In Russ.)

28. Kim E., Kim J.-Y., Lee J.-Y. Mathematical modeling of p53 pathways. International Journal of Molecular Sciences. 2019; 20(20):5179.

29. Zhao C., Zhang Y., Popel A.S. Mechanistic computational models of microRNA-mediated signaling networks in human diseases. International Journal of Molecular Sciences. 2019; 20(2):421.

30. Sun T., Cui J. A plausible model for bimodal p53 switch in DNA damage response. FEBS Letters. 2014; (588):815–821.

31. Tiana G., Jensen M.H., Sneppen K. Time delay as a key to apoptosis induction in the p53 network. Eur. Phys. J. B. 2002; (29):135–140.

32. Voropaeva O.F., Shokin Yu.I., Nepomnyashchikh L.M., Senchukova S.R. A mathematical model for functioning and regulation of p53 — Mdm2 biological system Moskow: RAMS Publ. House; 2014: 176. (In Russ.)

33. Voropaeva O.F., Senotrusova S.D. The passage from delay equation to ODE system in the model of the tumor markers network. Mathematical Modeling. 2017; 29(9):135–154. (In Russ.)

34. Goldbeter A., Koshland D.E. An amplified sensitivity arising from covalent modification in biological systems. PNAS. 1981; (78):6840–6844.

35. Tyson J.J., Chen K.C., Novak B. Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Current Opinion in Cell Biology. 2003; (15):221–231.

36. Myshkis A.D. General theory of differential equations with a delayed argument. Advances in Mathematical Sciences. 1949; (4):99–141. (In Russ.)

37. Voropaeva O.F., Tsgoev Ch.A. A numerical model of inflammation dynamics in the core of myocardial infarction. Journal of Applied and Industrial Mathematics. 2019; 13(2):372–383.

38. Muhlenbein H., Schlierkamp-Voosen D. Predictive models for the Breeder genetic algorithm. Evolutionary Computation. 1993; 1(1):25–49.

39. Sallaberger M., Fisler M., Michaud M., Eisele K., Casey K. The design of francis turbine runners by 3D Euler simulations coupled to a breeder genetic algorithm. In: Proc. of 20th IAHR Symp. Hydraulic Machinery and Systems, Aug. 6–9, 2000. Charlotte, North Carolina, USA. 2000: 10.

40. Cherny S.G., Chirkov D.V., Lapin V.N., Skorospelov V.A., Sharov S.V. Chislennoe modelirovanie techeniy v turbomashinakh [Numerical modeling of flows in turbomachines]. Novosibirsk: Nauka; 2006: 201.

41. Chen X., Chen J., Gan S., Guan H., Zhou Y., Ouyang Q., Shi J. DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control. BMC Biology. 2013; (11): 73.

42. Likhoshvai V.A., Fadeev S.I., Demidenko G.V., Matushkin Yu.G. Modeling nonbranching multistage synthesis by an equation with retarded argument. Journal of Applied and Industrial Mathematics. 2004; 7(1):73–94 (In Russ.)

43. Voropaeva O.F., Kozlova A.O., Senotrusova S.D. Numerical analysis of the transition from the equation with retarded argument to the ODE system in a mathematical model of the tumor markers network. Computational Technologies. 2016; 21(2):12–25. (In Russ.)

44. Oran E.S., Boris J.P. Numerical simulation of reactive flow. N.Y.: Elsevier Science Publishing Co.; 1987: 529.

45. Yang R., Huang B., Zhu Y., Li Y., Liu F., Shi J. Variable sensitivity to DNA damaging chemotherapeutic modulated by cell type-dependent bimodal p53 dynamics. Science Advances. 2018; 4(12):eaat5077. DOI:10.1101/149013.

46. Purvis J.E., Karhohs K.W., Mock C., Batchelor E., Loewer A., Lahav G. p53 dynamics control cell fate. Science. 2012; (336):1440–1444.

47. Raimondi L., De Luca A., Morelli E., Giavaresi G., Tagliaferri P., Tassone P., Amodio N. MicroRNAs: Novel crossroads between myeloma cells and the bone marrow microenvironment. BioMed Research International. 2016; (2016):ID6504593.

48. Climent M., Viggiani G., Chen Y.-W., Coulis G., Castaldi A. MicroRNA and ROS crosstalk in cardiac and pulmonary diseases. International Journal Molecular Sciences. 2020; (21):4370.

49. Tian X.-F., Ji F.-J., Zang H.-L., Cao H. Activation of the miR-34a/SIRT1/p53 signaling pathway contributes to the progress of liver fibrosis via inducing apoptosis in hepatocytes but not in HSCs. PLoS ONE. 2016; 11(7):e0158657.

50. Farghali H., Kemelo M.K., Kutinova C.N. SIRT1 modulators in experimentally induced liver injury. Oxidative Medicine and Cellular Longevity. 2019; (2019):ID8765954.

51. Solomon J.M., Pasupuleti R., Xu L., McDonagh T., Curtis R., DiStefano P.S., Huber L.J. Inhibition of SIRT1 Catalytic Activity Increases p53 Acetylation but Does Not Alter Cell Survival following DNA Damage. Molecular and Cellular Biology. 2006; 26(1):28–38. DOI:10.1128/MCB.26.1.28-38.2006.

52. Tramutola A., Pupo G., Domenico F.D., Barone E., Arena A., Lanzillotta C., Brokeaart D., Blarzino C., Head E., Butterfield D.A., Perluigi M. Activation of p53 in down syndrome and in the Ts65Dn mouse brain is associated with a pro-apoptotic phenotype. Journal of Alzheimer’s Disease. 2016; 52(1):359–371.

53. Tatarnikova O.G., Orlov M.A., Bobkova N.V. Beta-amyloid and tau-protein: Structure, interaction, and prion-like properties. Biochemistry. 2015; 80(13):1800–1819.

54. Buckley F. Modelling Down syndrome. Down Syndrome Research and Practice. 2008; (12):98–102.

55. Biomarkers definitions working group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clinical Pharmacology Therapeutics. 2001; 69(3):89–95.

56. Miroshnichenko I.I., Ptitsina S.N. Biomarkers in the modern medical and biologic practice. Biochemistry. 2009; 55(4):425–440. (In Russ.)

57. Iorio M.V., Visone R., Leva G., Donati V., Petrocca F., Casalini P., Taccioli C., Volinia S., Liu C.G., Alder H. et al. MicroRNA signatures in human ovarian cancer. Cancer Research. 2007; (67):8699–8707.

58. Shulenina L.V., Mihailov V.F., Ledin Е.V., Raeva N.F., Zasukhina G.D. Evaluation of p53-dependent system of maintaining the genome stability by content of microRNA and mRNA in blood of cancer patients. Medical Radiology and Radiation Safety. 2015; 60(1):5–14. (In Russ.)

59. Titov S.E., Demenkov P.S., Ivanov M.K., Malakhina E.S., Poloz T.L., Tsivlikova E.V., Ganzha M.S., Shevchenko S.P., Gulyaeva L.F., Kolesnikov N.N. Selection and validation of miRNAs as normalizers for profiling expression of microRNAs isolated from thyroid fine needle aspiration smears. Oncology Reports. 2016; (36):2501–2510.

60. Chang T.-C., Wentzel E., Kent O., Ramachandran K., Mullendore M., Lee K.H., Feldmann G., Yamakuchi M., Ferlito M., Lowenstein C. et al. Transactivation of miR34a by p53 broadly influences gene expression and promotes apoptosis. Molecular Cell. 2007; (26):745–752.

61. Bisio A., De Sanctis V., Del Vescovo V., Denti M.A., Jegga A.G., Inga A., Ciribilli Y. Identification of new p53 target microRNAs by bioinformatics and functional analysis. BMC Cancer. 2013; (13):552.

62. Iglin S.P. Teoriya veroyatnostey i matematicheskaya statistika na baze MATLAB [Probability theory and mathematical statistics based on MATLAB]. Kharkiv: NTU “KhPI”; 2006: 612. (In Russ.)

63. Senotrusova S.D. Vliyanie deregulyatsii r53-zavisimykh mikroRNK na diagnostiku degenerativnykh zabolevaniy: Rezul’taty matematicheskogo modelirovaniya [Influence of p53-dependent microRNA deregulation on the diagnosis of degenerative diseases: Results of mathematical modelling]. Proceedings of the International Scientific Conference “Actual problems of applied mathematics, computer science and mechanics”. Voronezh: Research publications; 2019: 1069–1073. (In Russ.)